Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-29

FDA Approved: MYCOPHENOLIC ACID — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved an original application for mycophenolic acid (Biocon Pharma Inc.), establishing a generic version of the immunosuppressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolic acid (mycophenolic acid)

Snippet

ORIG AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)